Bilateral diffuse uveal melanocytic proliferation (BDUMP) as ocular toxicity from durvalumab in advanced renal carcinoma
Eur J Cancer
.
2022 Aug:171:10-12.
doi: 10.1016/j.ejca.2022.04.037.
Epub 2022 Jun 13.
Authors
Luka Mihic Góngora
1
,
Carla Santalla
2
,
Débora Contreras Toledo
3
,
Tamara Díaz Vico
4
,
Emilio Esteban
5
Affiliations
1
Department of Medical Oncology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain. Electronic address: lukamihicgongora@gmail.com.
2
Department of Ophthalmology, Hospital Universitario San Agustín (HUSA), Avilés, Spain. Electronic address: carla_yoko@hotmail.com.
3
Department of Medical Oncology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
4
Department of General Surgery, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain. Electronic address: tamara.diaz.vico@gmail.com.
5
Department of Medical Oncology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain. Electronic address: eestebang@seom.org.
PMID:
35709599
DOI:
10.1016/j.ejca.2022.04.037
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal
Carcinoma*
Carcinoma, Renal Cell* / drug therapy
Cell Proliferation
Humans
Kidney Neoplasms* / drug therapy
Toxic Optic Neuropathy
Substances
Antibodies, Monoclonal
durvalumab